Compliance with Disclosure Obligations. The Company is a “disclosing entity” under the Corporations Act and, as such, is subject to regular reporting and disclosure obligations under both the Corporations Act and the ASX Listing Rules. These obligations require the Company to notify ASX of information about specific events and matters as they arise. In particular, the Company is obliged to continuously disclose to the market immediately any information which a reasonable person would expect to have a material effect on the price or the value of the Shares. The Company is also required to prepare and lodge with ASIC yearly and half-yearly financial statements accompanied by a directors’ statement and report, and an audit report or review. Copies of documents lodged with ASIC in relation to the Company may be obtained from, or inspected at, an ASIC office. The Company will provide a copy of each of the following documents, free of charge, to any person on request: (a) the annual financial report most recently lodged by the Company with ASIC, being the financial report of the Company for the year ended 30 June 2021; (b) any half-year financial report lodged by the Company with ASIC after the lodgement of the annual financial report referred to in paragraph (a) and before the lodgement of this Cleansing Notice with ASX; and (c) any continuous disclosure notices given by the Company to ASX after the lodgement of the annual financial report referred to in paragraph (a) and before the lodgement of this Cleansing Notice with ASX. A list of the continuous disclosure notices given by the Company to ASX after lodgement of the annual financial report referred to in paragraph (a) above and before the lodgement of this Cleansing Notice with ASX is set out in the table below.
Appears in 1 contract
Samples: Convertible Security Agreement
Compliance with Disclosure Obligations. The Company is a “disclosing entity” under the Corporations Act and, as such, is subject to regular reporting and disclosure obligations under both the Corporations Act and the ASX Listing Rules. These obligations require the Company to notify ASX of information about specific events and matters as they arise. In particular, the Company is obliged to continuously disclose to the market immediately any information which a reasonable person would expect to have a material effect on the price or the value of the Shares. The Company is also required to prepare and lodge with ASIC yearly and half-yearly financial statements accompanied by a directors’ statement and report, and an audit report or review. Copies of documents lodged with ASIC in relation to the Company may be obtained from, or inspected at, an ASIC office. The Company will provide a copy of each of the following documents, free of charge, to any person on request:
(a) the annual financial report most recently lodged by the Company with ASIC, being the financial report of the Company for the year ended 30 June 2021;
(b) any half-year financial report lodged by the Company with ASIC after the lodgement of the annual financial report referred to in paragraph (a) and before the lodgement of this Cleansing Notice with ASX; and
(c) any continuous disclosure notices given by the Company to ASX after the lodgement of the annual financial report referred to in paragraph (a) and before the lodgement of this Cleansing Notice with ASX. A list of the continuous disclosure notices given by the Company to ASX after lodgement of the annual financial report referred to in paragraph (a) above and before the lodgement of this Cleansing Notice with ASX is set out in the table below.. 29 July 2022 US$10M Financing Agreement signed with US Financier/Investor 28 July 2022 Proposed issue of securities - MXC 28 July 2022 Strategic Acquisition of 40% interest in ZAM Software Ltd 25 July 2022 Amended June Quarterly Reports (amended App. 4C) 25 July 2022 June Quarter Activities and Cash Flow Report 19 July 2022 Appointment of Chief Commercial Officer 14 July 2022 Long COVID Study Results for ArtemiC Support 8 July 2022 Approvals received for South African CimetrA Clinical Trial 6 July 2022 Launch of Medical Data Collection App - ZAM 27 June 2022 CimetrA anti-inflammatory pre-clinical study results 24 June 2022 US Market Update - CimetrA Clinical Trial Progress 16 June 2022 Glioblastoma pre-clinical trial results 6 June 2022 Cognicann Clinical Trial Results 18 May 2022 Response to ASX Aware Query 13 May 2022 s708A(5)(e) Cleansing Notice 13 May 2022 Application for quotation of securities - MXC 10 May 2022 Patent Granted for CannEpiL SNEDDS 9 May 2022 Change of Director's Interest Notice x 2 29 April 2022 March 2022 Quarterly Activity and Cash Flow Reports 26 April 2022 Appointment of London based CFO 21 April 2022 Patent Granted for CimetrA 12 April 2022 Change in directors' interests x 6 and cessation of CFO 7 April 2022 s708A(5)(e) Cleansing Notice 7 April 2022 Application for quotation of securities - MXC 7 April 2022 Notification of cessation of securities - MXC 6 April 2022 Notification of cessation of securities - MXC 5 April 2022 Sciensus Rare EU & UK Sales and Distribution Agreement 10 March 2022 Retirement of Joint Company Secretary 1 March 2022 Half Yearly Report and Accounts 22 February 2022 s708A(5)(e) Cleansing Notice 22 February 2022 Application for quotation of securities - MXC 17 February 2022 Results of Meeting 2 February 2022 s708A(5)(e) Cleansing Notice 2 February 2022 Application for quotation of securities - MXC 2 February 2022 Application for quotation of securities - MXC 31 January 2022 Quarterly Activities/Appendix 4C Cash Flow Report 14 January 2022 General Meeting Notice of Meeting 14 January 2022 General Meeting Notice of Access/Proxy Form 12 January 2022 Response to ASX Query 7 January 2022 ArtemiC receives Indian importation and sales approval 21 December 2021 ArtemiC Long COVID Syndrome Clinical Study Commenced 16 December 2021 Notification regarding unquoted securities - MXC 8 December 2021 s708A(5)(e) Cleansing Notice 8 December 2021 Application for quotation of securities - MXC 8 December 2021 Application for quotation of securities - MXC 1 December 2021 s708A(5)(e) Cleansing Notice 1 December 2021 Proposed issue of securities - MXC 1 December 2021 UK Capital Raising Completed 30 November 2021 Trading Halt 25 November 2021 Production Completed of A$1M ArtemiC Order from SPC 25 November 2021 Results of 2021 Annual General Meeting 24 November 2021 Issue of Shares and Tranche 1 Note Maturity Extension 24 November 2021 Proposed issue of securities - MXC 24 November 2021 Appendix 3Y - Change of Director's Interest Notice 24 November 2021 Application for quotation of securities - MXC 24 November 2021 Application for quotation of securities - MXC 23 November 2021 US Supply and Distribution Agreement Update 19 November 2021 AGM Webcast Registration Details 17 November 2021 Notice of upcoming release of shares from voluntary escrow 12 November 2021 Section 323DB Jobkeeper Receipts Notice 12 November 2021 Notification regarding unquoted securities - MXC 3 November 2021 Malta Cimetra Production Facility Update 2 November 2021 Cimetra Dose Finding Study Approval 26 October 2021 Quarterly Activities/Appendix 4C Cash Flow Report
Appears in 1 contract
Compliance with Disclosure Obligations. The Company is a “disclosing entity” under the Corporations Act and, as such, is subject to regular reporting and disclosure obligations under both the Corporations Act and the ASX Listing Rules. These obligations require the Company to notify ASX of information about specific events and matters as they arise. In particular, the Company is obliged to continuously disclose to the market immediately any information which a reasonable person would expect to have a material effect on the price or the value of the Shares. The Company is also required to prepare and lodge with ASIC yearly and half-half- yearly financial statements accompanied by a directors’ statement and report, and an audit report or review. Copies of documents lodged with ASIC in relation to the Company may be obtained from, or inspected at, an ASIC office. The Company will provide a copy of each of the following documents, free of charge, to any person on request:
(a) the annual financial report most recently lodged by the Company with ASIC, being the financial report of the Company for the year ended 30 June 20212023;
(b) any half-year financial report lodged by the Company with ASIC after the lodgement of the annual financial report referred to in paragraph (a) and before the lodgement of this Cleansing Notice with ASX; and
(c) any continuous disclosure notices given by the Company to ASX after the lodgement of the annual financial report referred to in paragraph (a) and before the lodgement of this Cleansing Notice with ASX. A list of the continuous disclosure notices given by the Company to ASX after lodgement of the annual financial report referred to in paragraph (a) above and before the lodgement of this Cleansing Notice with ASX is set out in the table below.. 29/09/2023 Micro Plant Delivers Critical 4N HPA Milestone 03/10/2023 Updated - Micro Plant Delivers Critical 4N HPA Milestone 03/10/2023 Updated – Testwork Delivers HPA Flowsheet Enhancements 06/10/2023 Details of Upcoming AGM 09/10/2023 Tranche 2 Strategic Funding Facility From US Shareholder 09/10/2023 Update- Proposed issue of securities - CMX 09/10/2023 Proposed Issue of Securities - CMX 09/10/2023 Proposed Issue of Securities - CMX 09/10/2023 Cancel - Proposed Issue of Securities - CMX 09/10/2023 Proposed Issue of Securities - CMX 09/10/2023 Section 708A(12C)(e)
Appears in 1 contract
Compliance with Disclosure Obligations. The Company is a “disclosing entity” under the Corporations Act and, as such, is subject to regular reporting and disclosure obligations under both the Corporations Act and the ASX Listing Rules. These obligations require the Company to notify ASX of information about specific events and matters as they arise. In particular, the Company is obliged to continuously disclose to the market immediately any information which a reasonable person would expect to have a material effect on the price or the value of the Shares. The Company is also required to prepare and lodge with ASIC yearly and half-half- yearly financial statements accompanied by a directors’ statement and report, and an audit report or review. Copies of documents lodged with ASIC in relation to the Company may be obtained from, or inspected at, an ASIC office. The Company will provide a copy of each of the following documents, free of charge, to any person on request:
(a) the annual financial report most recently lodged by the Company with ASIC, being the financial report of the Company for the year ended 30 June 20212022;
(b) any half-year financial report lodged by the Company with ASIC after the lodgement of the annual financial report referred to in paragraph (a) and before the lodgement of this Cleansing Notice with ASX; and
(c) any continuous disclosure notices given by the Company to ASX after the lodgement of the annual financial report referred to in paragraph (a) and before the lodgement of this Cleansing Notice with ASX. A list of the continuous disclosure notices given by the Company to ASX after lodgement of the annual financial report referred to in paragraph (a) above and before the lodgement of this Cleansing Notice with ASX is set out in the table below.. 10/08/2023 Update – Proposed issue of securities - CMX 10/08/2023 Update – Proposed issue of securities - CMX 10/08/2023 Update – Proposed issue of securities - CMX 04/08/2023 Proposed issue of securities - CMX 04/08/2023 Proposed issue of securities - CMX 04/08/2023 Proposed issue of securities - CMX 04/08/2023 Proposed issue of securities - CMX 04/08/2023 ChemX Secures Strategic Funding & New CEO 02/08/2023 Trading Halt 31/07/2023 Appendix 5B 31/07/2023 Quarterly Activities Report 15/06/2023 ChemX USA Roadshow Presentation 5/06/2023 ChemX Approves Construction of Resized HPA Pilot Plant 9/05/2023 Highest Grade Thick Intercepts of Manganese 4/05/2023 ChemX Investor Presentation 27/04/2023 More Significant Manganese Assays 24/04/2023 Quarterly Activities Report 24/04/2023 Quarterly Appendix 5B Cash Flow Report 17/04/2023 Significant Manganese Assays 30/03/2023 ChemX signs MoU with lithium-ion battery leader C4V 24/03/2023 Change of Company Secretary 8/03/2023 Half Yearly Report and Accounts 8/03/2023 Manganese Drilling Campaign Completed 10/02/2023 Notification regarding unquoted securities - CMX 10/02/2023 Initial Director's Interest Notice - TBB 10/02/2023 ChemX Appoints Xxxx Xxxxxx as Non-Executive Director 10/02/2023 Proposed issue of securities - CMX 6/02/2023 Final Director's Interest Notice 6/02/2023 Notification of cessation of securities - CMX 6/02/2023 Board and Management Changes 30/01/2023 Quarterly Activities Report 30/01/2023 Appendix 5B Cash Flow Report 16/01/2023 Battery Grade Manganese Exploration Commences 4/01/2023 Change in Substantial Holding - CMX 3/01/2023 Application for quotation of securities - CMX 22/12/2022 Notice of Release of Escrowed Securities 16/12/2022 Battery Grade Manganese Exploration & Development Update 2/12/2022 Notification regarding unquoted securities - CMX 2/12/2022 Notification of cessation of securities - CMX 22/11/2022 Change of Director's Interest Notice- APV 22/11/2022 Change of Director's Interest Notice - WNH 22/11/2022 Change of Director's Interest Notice - KPY 18/11/2022 Notification regarding unquoted securities - CMX 18/11/2022 Proposed issue of securities - CMX 11/11/2022 AGM - Results 11/11/2022 AGM - MD's Presentation 11/11/2022 AGM - Chair's Address 9/11/2022 Integrated HPA Facility in Perth Commissioned 27/10/2022 Final Director's Interest Notice 27/10/2022 ChemX Board & Management Changes 26/10/2022 Quarterly Activities Report 26/10/2022 Appendix 5B Cash Flow Report 21/10/2022 CMX - Addendum to Notice of Annual General Meeting 20/10/2022 ChemX - Couth-West Connect ASX Showcase 19/10/2022 Initial Director's Interest Notice - APV 19/10/2022 ChemX Appoints Xxxxx Xxxxxxx as Non-Executive Director 10/10/2022 CMX - Notice of AGM and Proxy Form 7/10/2022 ChemX Drill Results Confirm Significant Kaolin Prospect 6/10/2022 Notification regarding unquoted securities - CMX 3/10/2022 CMX Signs MOU with PBT & Appoints GM Battery Tech
Appears in 1 contract
Compliance with Disclosure Obligations. The Company is a “disclosing entity” under the Corporations Act and, as such, is subject to regular reporting and disclosure obligations under both the Corporations Act and the ASX Listing Rules. These obligations require the Company to notify ASX of information about specific events and matters as they arise. In particular, the Company is obliged to continuously disclose to the market immediately any information which a reasonable person would expect to have a material effect on the price or the value of the Shares. The Company is also required to prepare and lodge with ASIC yearly and half-half- yearly financial statements accompanied by a directors’ statement and report, and an audit report or review. Copies of documents lodged with ASIC in relation to the Company may be obtained from, or inspected at, an ASIC office. The Company will provide a copy of each of the following documents, free of charge, to any person on request:
(a) the annual financial report most recently lodged by the Company with ASIC, being the financial report of the Company for the year ended 30 June 20212023;
(b) any half-year financial report lodged by the Company with ASIC after the lodgement of the annual financial report referred to in paragraph (a) and before the lodgement of this Cleansing Notice with ASX; and
(c) any continuous disclosure notices given by the Company to ASX after the lodgement of the annual financial report referred to in paragraph (a) and before the lodgement of this Cleansing Notice with ASX. A list of the continuous disclosure notices given by the Company to ASX after lodgement of the annual financial report referred to in paragraph (a) above and before the lodgement of this Cleansing Notice with ASX is set out in the table below.. 29/09/2023 Micro Plant Delivers Critical 4N HPA Milestone 03/10/2023 Updated - Micro Plant Delivers Critical 4N HPA Milestone 03/10/2023 Updated – Testwork Delivers HPA Flowsheet Enhancements 06/10/2023 Details of Upcoming AGM 09/10/2023 Tranche 2 Strategic Funding Facility From US Shareholder
Appears in 1 contract
